A clinical case of adult-onset Still's disease resistant to therapy with tumor necrosis factor-alpha inhibitors and interleukin-6 inhibitors
The basis of the clinical picture of adult-onset Still's disease is a triad of symptoms, includingfever, arthralgia/arthritis, and characteristic rash called «Still rash». The first line of therapy includes glucocorticoids, synthetic disease-modifying anti-rheumatic drugs; biological agents, su...
Main Authors: | R. R. Samigullina, E. A. Vasilenko, V. I. Mazurov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA-PRESS LLC
2019-03-01
|
Series: | Современная ревматология |
Subjects: | |
Online Access: | https://mrj.ima-press.net/mrj/article/view/892 |
Similar Items
-
Management of adult-onset Still’s disease with interleukin-1 inhibitors: evidence- and consensus-based statements by a panel of Italian experts
by: Serena Colafrancesco, et al.
Published: (2019-12-01) -
Therapy with canakinumab for adult-onset still's disease
by: E. L. Nasonov
Published: (2019-04-01) -
Response to Interleukin-1 Inhibitors in 140 Italian Patients with Adult-Onset Still’s Disease: A Multicentre Retrospective Observational Study
by: Serena Colafrancesco, et al.
Published: (2017-06-01) -
Development and Role in Therapy of Canakinumab in Adult-Onset Still’s Disease
by: Paola Galozzi, et al.
Published: (2018-09-01) -
Different Features of Interleukin-37 and Interleukin-18 as Disease Activity Markers of Adult-Onset Still’s Disease
by: Seoung Wan Nam, et al.
Published: (2021-02-01)